Evidence-based two-and-seven criteria according to tumor number and size best help to predict survival of patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization

D. Xia,W. Bai,M. Huang,J. Sun,E. Wang, H. Li,Jia Li,H. Zhao,X. Pan,S. Chen, W. Gong,X. Zhu, G. Shao, W. Mu,Z. Chen, J. Wu,J. Liu, J. Song,Chen-Yu Zhang, H. Shi,Zhigang Li, S. Yang,Weiqing Wang, Y. Zheng, J. Xu, J. Yuan, Xiaoying Li,Junqi Niu,Zhanxin Yin,Daiming Fan,J. Xia,Guohong Han

Journal of Hepatology(2017)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要